Results 201 to 210 of about 5,099,009 (221)

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of Oncology, 2015
Chan Yoon Cheah, Dai Chihara, Nathan H Fowler   +2 more
exaly  

Acalabrutinib in mantle cell lymphoma

The Lancet, 2018
Prashant, Kapoor, Stephen M, Ansell
openaire   +2 more sources

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Annals of Oncology, 2009
Benjamin Djulbegovic, E Epner, J P Leonard   +2 more
exaly  

Observation as the initial management strategy in patients with mantle cell lymphoma

Annals of Oncology, 2017
Randy D Gascoyne, Diego Villa, D W Scott
exaly  

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage

Cancer Cell, 2016
Angelika Merkel, Renée Beekman, Sílvia Beà   +2 more
exaly  

Central nervous system involvement in mantle cell lymphoma

Annals of Oncology, 2008
Francesc Bosch, A López-Guillermo
exaly  

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

Annals of Oncology, 2002
Yukio Kobayashi, M Taniwaki
exaly  

Hematopoietic stem cell transplantation in mantle cell lymphoma

Annals of Oncology, 2005
Apar Kishor Ganti, Philip J Bierman, J O Armitage   +2 more
exaly  

Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma

Annals of Oncology, 2010
Andrew D Zelenetz, C H Moskowitz, Carol S Portlock   +2 more
exaly  

Management of mantle cell lymphoma

Annals of Hematology, 1999
P, Meusers, J, Hense
openaire   +2 more sources